CVC acquires chemical company Taminco
CVC Capital Partners Ltd., Europe’s second-biggest buyout firm, agreed to buy Belgian chemical company Taminco NV for €800 million ($1.1 billion) to add a maker of ingredients used in the pharmaceutical industry.
Taminco produces alkylamines and derivatives, key building blocks for the
pharmaceutical, agrochemical, animal feed and water treatment industries.
Taminco was established in its current form following a carve-out from UCB in
October 2003.
The chemical company recently acquired the amines business
of Air Products, nearly doubling the firm’s size and firmly positioning itself
as the global market leader in methylamines, methylamine derivatives and higher
amines, supplying clients in the drug, agrochemical, animal feed and
water-treatment industries.
CVC purchased Ghent-based Taminco from Dutch
investment firm AlpInvest Partners NV in an auction run by Merrill Lynch &
Co, the London-based private-equity company.
Taminco employs 850 people
at plants in Germany, the US, Brazil and China, as well as Belgium, and predicts
sales of about €600 million this year, CVC said.
“Our priorities and our
business structure will remain unchanged,” Taminco Chief Executive Officer Pol
Vanderhaeghen said in the CVC statement. “On the contrary, Taminco will be even
more focused on globalizing its activities and integrating into new selected
derivatives.”
